Publicaciones (34) Publicaciones de Luis Federico Sanchez Del Campo Ferrer

2023

  1. Editorial: Cell stress responses and metabolic reprogramming in skin diseases

    Frontiers in Cell and Developmental Biology

  2. Targeting protein methylation in pancreatic cancer cells results in KRAS signaling imbalance and inhibition of autophagy

    Cell Death and Disease, Vol. 14, Núm. 11

2021

  1. Acriflavine, a potent inhibitor of HIF-1α, disturbs glucose metabolism and suppresses ATF4-protective pathways in melanoma under non-hypoxic conditions

    Cancers, Vol. 13, Núm. 1, pp. 1-17

  2. BRN2 is a non-canonical melanoma tumor-suppressor

    Nature Communications, Vol. 12, Núm. 1

  3. MITF induces escape from innate immunity in melanoma

    Journal of Experimental and Clinical Cancer Research, Vol. 40, Núm. 1

  4. The two faces of the Integrated Stress Response in cancer progression and therapeutic strategies

    International Journal of Biochemistry and Cell Biology

2020

  1. PRMT1-dependent methylation of BRCA1 contributes to the epigenetic defense of breast cancer cells against ionizing radiation

    Scientific Reports, Vol. 10, Núm. 1

2017

  1. Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma

    Genes and Development, Vol. 31, Núm. 1, pp. 18-33

2016

  1. Lebein, A snake venom disintegrin, Induces apoptosis in human melanoma cells

    Toxins, Vol. 8, Núm. 7

  2. Targeting the epigenetics of the DNA damage response in breast cancer

    Cell Death and Disease, Vol. 7

  3. Tumor suppressor SET9 guides the epigenetic plasticity of breast cancer cells and serves as an early-stage biomarker for predicting metastasis

    Oncogene, Vol. 35, Núm. 47, pp. 6143-6152

2015

  1. MITF is a critical regulator of the carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) in malignant melanoma

    Pigment Cell and Melanoma Research, Vol. 28, Núm. 6, pp. 736-740

  2. Targeting the epigenetic machinery of cancer cells

    Oncogene, Vol. 34, Núm. 2, pp. 135-143

2013

  1. Analysis of Dll4 regulation reveals a combinatorial role for Sox and Notch in arterial development

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, Núm. 29, pp. 11893-11898

  2. Cómo convertir la resistencia en el talón de Aquiles del melanoma

    Eubacteria, Núm. 32

  3. Directed Phenotype Switching as an Effective Antimelanoma Strategy

    Cancer Cell, Vol. 24, Núm. 1, pp. 105-119

  4. Suppression of antifolate resistance by targeting the myosin Va trafficking pathway in melanoma

    Neoplasia (United States), Vol. 15, Núm. 7, pp. 826-839

2012

  1. Changes in the expression and structure of cholinesterases in excitable and non-excitable tissues of the merosin-deficient Lama2dy mouse, a model of congenital muscular dystrophy

    Cholinesterase: Production, Uses and Health Effects (Nova Science Publishers, Inc.), pp. 1-32

  2. Melanoma coordinates general and cell-specific mechanisms to promote methotrexate resistance

    Experimental Cell Research, Vol. 318, Núm. 10, pp. 1146-1159

2011

  1. Comparison of a Pair of Synthetic Tea-Catechin-Derived Epimers: Synthesis, Antifolate Activity, and Tyrosinase-Mediated Activation in Melanoma

    ChemMedChem, Vol. 6, Núm. 3, pp. 440-449